Nexocyte
Plattform
Biopixlar
Encellsverktyg
Publikationer
Patent
Pipeline
Diabetes
Hjärtsjukdom
Partnerskap
Om oss
Nyheter & Evenemang
Ledarskap & Rådgivare
Kontakt
Investerare
Pressmeddelanden
Rapporter
Finansiell kalender
Finansiella dokument
Ledning och styrelse
Aktien
Årsstämma 2025
Kontakt
EN
EN
SV
kontakta
EN
SV
Home
/
Platform
/
Publications
/
Blocking characteristics of hERG, hNav1.5, and hKvLQT1/hminK after administration of the novel anti-arrhythmic compound AZD7009
Blocking characteristics of hERG, hNav1.5, and hKvLQT1/hminK after administration of the novel anti-arrhythmic compound AZD7009
Frida Persson, Leif Carlsson, Göran Duker, Ingemar Jacobson
2005
-
Journal of Cardiovascular Electrophysiology
View publication
Download
Share this publication: